ストックスクリーナーアプリを入手
300.08
0.62%
-1.86
アフターアワーズ：
298.50
-1.58
-0.53%
前日終値:
$301.94
開ける：
$300.73
24時間の取引高:
2.66M
Relative Volume:
1.03
時価総額：
$161.35B
収益：
$34.13B
当期純損益:
$5.93B
株価収益率:
27.38
EPS:
10.96
ネットキャッシュフロー:
$10.92B
1週間 パフォーマンス:
-1.15%
1か月 パフォーマンス:
+0.62%
6か月 パフォーマンス:
-2.51%
1年 パフォーマンス:
-7.73%
1日の値動き範囲:
$297.02
$302.10
1週間の範囲:
$292.59
$305.57
52週間の値動き範囲:
$253.30
$339.17
Amgen Inc Stock (AMGN) Company Profile
AMGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
300.08 | 162.35B | 34.13B | 5.93B | 10.92B | 10.96 |
|
LLY
Lilly Eli Co
|
765.95 | 690.36B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
170.74 | 411.92B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
198.55 | 348.32B | 58.33B | 3.76B | 15.39B | 2.10 |
|
NVS
Novartis Ag Adr
|
117.73 | 228.10B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
80.79 | 200.53B | 63.62B | 16.41B | 17.04B | 6.49 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | 再開されました | Guggenheim | Neutral |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
| 2024-11-14 | 開始されました | Citigroup | Neutral |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-14 | ダウングレード | Truist | Buy → Hold |
| 2024-09-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-05-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 再開されました | Raymond James | Mkt Perform |
| 2024-02-07 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | アップグレード | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-11-02 | アップグレード | Truist | Hold → Buy |
| 2023-10-20 | 再開されました | JP Morgan | Neutral |
| 2023-10-17 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 再開されました | BofA Securities | Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-04-24 | 繰り返されました | Oppenheimer | Outperform |
| 2023-03-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 繰り返されました | Truist | Buy |
| 2022-11-18 | 開始されました | Credit Suisse | Underperform |
| 2022-10-31 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2022-10-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-09 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-09 | 繰り返されました | Jefferies | Buy |
| 2022-02-09 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 繰り返されました | Oppenheimer | Outperform |
| 2022-02-09 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Buy |
| 2021-11-19 | 開始されました | BMO Capital Markets | Market Perform |
| 2021-09-23 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 開始されました | Daiwa Securities | Buy |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-10-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | アップグレード | Truist | Hold → Buy |
| 2020-10-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | ダウングレード | Truist | Buy → Hold |
| 2020-10-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 再開されました | Guggenheim | Neutral |
| 2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
| 2020-03-30 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-01-31 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-17 | 再開されました | Morgan Stanley | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-11-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 再開されました | BofA/Merrill | Neutral |
| 2019-08-19 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-05-23 | アップグレード | Citigroup | Neutral → Buy |
すべてを表示
Amgen Inc (AMGN) 最新ニュース
Mitsubishi UFJ Trust & Banking Corp Purchases 7,308 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen: Q2 Earnings Snapshot - The Washington Post
Amgen's Q2 Earnings Beat and Revenue Growth Outpace 122nd Volume Rank and Biosimilar Challenges - AInvest
Amgen Inc. (NASDAQ:AMGN) Plans Quarterly Dividend of $2.38 - MarketBeat
Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue - TradingView
Amgen Plans AI Investment Amid Strong Sales Growth - insights.citeline.com
Earnings call transcript: Amgen beats Q2 2025 earnings expectations By Investing.com - Investing.com Canada
Amgen (AMGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates - Nasdaq
Amgen Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Amgen Q2 2025 slides: Revenue up 9%, EPS surges 21% as guidance raised - Investing.com India
Amgen beat Q2 revenue and profit, stock trades flat (AMGN) - Seeking Alpha
Amgen Posts Higher Profit, Revenue On Sales Growth Among Products - The Wall Street Journal
Amgen Beats Expectations As New Drugs Take Center Stage - Finimize
Amgen stock steady despite robust Q2 beat By Investing.com - Investing.com Nigeria
Amgen quarterly results beat Wall Street estimates By Reuters - Investing.com
Amgen Lifts 2025 Guidance After Drug Sales Beat Expectations - Bloomberg.com
Amgen Inc. Q2 Profit Increases, Beats Estimates - Nasdaq
Amgen profit rises, weight-loss data expected in 4th quarter - MarketScreener
PREVIEW: Amgen slips ahead of results, focus on obesity drugs - TradingView
Amgen, Lilly Survive Bid to Dismiss Claims in Drug Discount Suit - Bloomberg Law News
Blair William & Co. IL Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Banco Santander S.A. Buys 6,119 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen, Lilly can continue fight over alleged improper drug discounts, judge rules - Endpoints News
Stocks to Watch Afterhours: AMD, Amgen, Snap - The Wall Street Journal
Stock Analysis | Amgen OutlookA Mixed Bag of Signals Amid Strong Fundamentals - AInvest
Natixis Advisors LLC Has $101.15 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
XTX Topco Ltd Boosts Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Baader Bank Aktiengesellschaft Sells 1,832 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
US Bancorp DE Sells 6,952 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Hoxton Planning & Management LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Neuroendocrine Prostate Cancer Market Forecast Shows Accelerated CAGR Due to Diagnostic Advancements and Research Investment | DelveInsight - GlobeNewswire Inc.
Leerink Partners Reiterates a Neutral Stance on Amgen (AMGN) - MSN
Amgen Q2 earnings preview: What to expect? - Seeking Alpha
Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts? - TradingView
Buy or Sell Amgen Stock Ahead of Its Earnings? - Forbes
How Will Amgen Stock React To Its Upcoming Earnings? - Trefis
Uncovering Potential: Amgen's Earnings Preview - 富途牛牛
NewEdge Wealth LLC Has $36.08 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Raiffeisen Bank International AG Acquires 3,466 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Argent Trust Co Acquires 1,097 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Liberty Wealth Management LLC Buys 14,047 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
DCF Advisers LLC Has $2.13 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bank of Nova Scotia Sells 381,790 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
NJ State Employees Deferred Compensation Plan Trims Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
TIAA Trust National Association Decreases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Does Amgen’s (AMGN) Steady Dividend Signal Strength in Its Evolving Pipeline Strategy? - simplywall.st
Do Wall Street Analysts Like Amgen Stock? - MSN
Torray Investment Partners LLC Has $17.86 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Q2 Earnings: A Critical Inflection Point for Biotech's Leading Innovator - AInvest
Earnings To Watch: Amgen (AMGN) Reports Q2 Results Tomorrow - Yahoo Finance
Amgen Inc (AMGN) 財務データ
収益
当期純利益
現金流量
EPS
3.26%
5.18%
大文字化:
|
ボリューム (24 時間):